Company news
Prolight Diagnostics Ab (NGM:PRLD) news
Prolight Diagnostics Ab news releases on 6ix. Latest, Sep 7, 2026: Prolight signs supply agreement with BRAINBox valued at USD 3.9 million for the first year
Press releases & updates
Prolight signs supply agreement with BRAINBox valued at USD 3.9 million for the first year
September 7, 2026
Prolight Diagnostics publishes half-year report, 2026
August 27, 2026
Prolight signs GBP 2.24m development agreement with BRAINBox
July 13, 2026
Prolight receives Notice of Allowance for Psyros® patent in the US
July 8, 2026
PRLD: Psyros POC platform reached design freeze; Q1 EBIT loss -10.4 MSEK, strong liquidity post-quarter
May 26, 2026
Prolight Diagnostics AB (publ) publishes annual report for 2025
May 5, 2026
Prolight Diagnostics achieves design freeze for Psyros® instrument
April 29, 2026
Prolight secures second patent in Japan for Psyros® technology
April 28, 2026
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
April 21, 2026
Prolight selected as semi-finalist for ADLM 2026 Disruptive Technology Award Competition
April 14, 2026
Prolight Diagnostics publishes investorletter for March 2026
March 24, 2026
Prolight Diagnostics’ POC system Psyros attracted significant attention at the recently concluded international WHX Labs congress
March 9, 2026
Biostock publishes an article after Prolight published its Year-End Report for 2025
March 3, 2026
PRLD: Losses increased but cash reserves strengthened; commercial launch of Psyros platform advances
February 26, 2026
Biostock publishes an article describing how Prolight scales-up cartridge manufacturing
February 2, 2026
Biostock publishes an article about Prolight finalises instrument design and prepare for pilot manufacturing
January 30, 2026
Prolight Diagnostics publishes investorletter for January 2026
January 28, 2026
Biostock publishes an article about the key milestone toward commercialisation - assay design freeze
December 18, 2025
Prolight Diagnostics achieves assay design freeze for Psyros™ point-of-care cartridge – A key milestone toward commercialisation
December 17, 2025
PRLD: Losses increased amid product development, but funding and patent milestones support 2027 launch
November 27, 2025
BioStock: Final adjustments and validation take center stage at Prolight Diagnostics
November 17, 2025
Prolight Diagnostics publishes investor letter for November 2025
November 5, 2025
NOTICE OF EXTRAORDINARY GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
October 17, 2025
PRLD: Strong clinical progress and financing position support ongoing POC platform commercialization
August 28, 2025
PRLD: Psyros POC platform advances with strong patent wins and pivotal clinical studies ahead
May 30, 2025
PRLD: Breakthroughs in POC diagnostics and IP, but future hinges on successful rights issue
February 28, 2025
PRLD: Psyros POC system development accelerates, with new funding and strong market growth outlook
November 27, 2024
PRLD: Psyros POC platform advances with new funding, strong industry interest, and robust cash position
August 28, 2024